Drug approved for difficult-to-manage type 2 diabetes

Getty/Drazen_

A drug that may be more effective than semaglutide is to be available on the NHS for patients with type 2 diabetes.

In final draft guidance, the National Institute for Health and Care Excellence recommends tirzepatide, also known as Mounjaro, a treatment developed by Eli Lilly, in adults alongside diet and exercise.